170 related articles for article (PubMed ID: 37750208)
1. Neurodevelopmental Outcome of Infants with Transient Hypothyroxinemia of Prematurity in a Newborn Intensive Care Unit.
Aygün E; Yilmaz Semerci S; Çakıl Sağlık A; Yurdakul Ertürk E
J Clin Res Pediatr Endocrinol; 2024 Mar; 16(1):60-68. PubMed ID: 37750208
[TBL] [Abstract][Full Text] [Related]
2. Clinical indicators that influence a clinician's decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia.
Yilmaz A; Ozer Y; Kaya N; Cakir AD; Culpan HC; Perk Y; Vural M; Evliyaoglu O
Ital J Pediatr; 2023 Aug; 49(1):105. PubMed ID: 37644575
[TBL] [Abstract][Full Text] [Related]
3. Effect of levothyroxine supplementation in extremely low birth weight infants with transient hypothyroxinemia of prematurity.
Yoon SA; Chang YS; Yang M; Ahn SY; Sung SI; Cho HS; Park WS
Sci Rep; 2022 Jun; 12(1):9717. PubMed ID: 35690687
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of transient hypothyroxinemia of prematurity: a prospective cohort study.
Maneenil G; Juthong M; Thatrimontrichai A; Janjindamai W; Dissaneevate S; Jaruratanasirikul S
Turk J Pediatr; 2023; 65(4):562-571. PubMed ID: 37661671
[TBL] [Abstract][Full Text] [Related]
5. The factors associated with transient hypothyroxinemia of prematurity.
Yilmaz A; Ozer Y; Kaya N; Turan H; Acar HC; Ercan O; Perk Y; Evliyaoglu O; Vural M
BMC Pediatr; 2021 Aug; 21(1):344. PubMed ID: 34388993
[TBL] [Abstract][Full Text] [Related]
6. Transient hypothyroxinemia of prematurity and its risk factors in an extramural neonatal intensive care unit.
Rai R; Singh DK; Bhakhri BK
Arch Endocrinol Metab; 2021 Nov; 65(6):723-729. PubMed ID: 33909379
[TBL] [Abstract][Full Text] [Related]
7. General Movement assessment and neurodevelopmental trajectory in extremely preterm infants with hypothyroxinaemia of prematurity (THOP).
Goel D; Luig M; Maheshwari R; D'Cruz D; Goyen TA
Early Hum Dev; 2020 May; 144():104886. PubMed ID: 31668678
[TBL] [Abstract][Full Text] [Related]
8. Transient hypothyroxinemia of prematurity is associated with abnormal cranial ultrasound and illness severity.
Huang CB; Chen FS; Chung MY
Am J Perinatol; 2002 Apr; 19(3):139-47. PubMed ID: 12012289
[TBL] [Abstract][Full Text] [Related]
9. Transient hypothyroxinemia of prematurity and problem behavior in young adulthood.
Hollanders JJ; van der Pal SM; Verkerk PH; Rotteveel J; Finken MJ;
Psychoneuroendocrinology; 2016 Oct; 72():40-6. PubMed ID: 27343725
[TBL] [Abstract][Full Text] [Related]
10. No Association Between Transient Hypothyroxinemia of Prematurity and Neurodevelopmental Outcome in Young Adulthood.
Hollanders JJ; Israëls J; van der Pal SM; Verkerk PH; Rotteveel J; Finken MJ;
J Clin Endocrinol Metab; 2015 Dec; 100(12):4648-53. PubMed ID: 26480285
[TBL] [Abstract][Full Text] [Related]
11. Effect of L-thyroxine supplementation on very low birth weight infants with transient hypothyroxinemia of prematurity at 3 years of age.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Perinatol; 2017 May; 37(5):602-605. PubMed ID: 28125093
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants.
Tan LO; Tan MG; Poon WB
PLoS One; 2019; 14(9):e0222018. PubMed ID: 31513612
[TBL] [Abstract][Full Text] [Related]
13. Association Between Retinopathy of Prematurity in Very-Low-Birth-Weight Infants and Neurodevelopmental Impairment.
Han G; Lim DH; Kang D; Cho J; Guallar E; Chang YS; Chung TY; Kim SJ; Park WS
Am J Ophthalmol; 2022 Dec; 244():205-215. PubMed ID: 35998681
[TBL] [Abstract][Full Text] [Related]
14. Association of inotrope use with neurodevelopmental outcomes in infants <29 weeks gestation: a retrospective cohort study.
Doucette SM; Kelly EN; Church PT; Lee S; Shah V;
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6044-6052. PubMed ID: 33827395
[TBL] [Abstract][Full Text] [Related]
15. Inositol in preterm infants at risk for or having respiratory distress syndrome.
Howlett A; Ohlsson A; Plakkal N
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental evaluation of very low birth weight infants with transient hypothyroxinemia at corrected age of 18-24 months.
Dilli D; Eras Z; Andiran N; Dilmen U; Sakrucu ED
Indian Pediatr; 2012 Sep; 49(9):711-5. PubMed ID: 22791672
[TBL] [Abstract][Full Text] [Related]
17. Current knowledge of transient hypothyroxinemia of prematurity: to treat or not to treat?
Iijima S
J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2591-2597. PubMed ID: 29447027
[TBL] [Abstract][Full Text] [Related]
18. The differential associative relationship between early risk factors, neonatal morbidities and early neurodevelopmental outcome in preterm infants <29 weeks' gestation.
Huang HB; Hicks M; Zhang QS; Watt MJ; Lin F; Wan XQ; Cheung PY
Early Hum Dev; 2023 Nov; 186():105859. PubMed ID: 37738923
[TBL] [Abstract][Full Text] [Related]
19. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
20. Factors Affecting Metabolic Bone Disease of Prematurity: Is Hypothyroxinemia Included?
Dursun M; Ozcabi B; Sariaydin M
Sisli Etfal Hastan Tip Bul; 2022; 56(1):84-90. PubMed ID: 35515963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
